Top Biotech Companies (3,704)
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with...
Roche's Top Stability & Growth Strengths
Strong Market Position & Advantage: Roche is the global leader in in‑vitro diagnostics and remains a top‑tier biopharma with a significant oncology footprint. The dual Pharmaceuticals–Diagnostics model is a strategic differentiator at scale.
Strong Revenue Growth: Group sales rose 7% at constant exchange rates in 2025 and 6% at CER in Q1 2026, with both divisions contributing. Guidance for 2026 indicates continued mid–single‑digit CER growth.
Profitability: Profitability improved in 2025 alongside sales, with higher IFRS net income and core EPS growth. Management pointed to capacity to keep investing while rewarding shareholders.
We Engineer Solutions for the Nation’s Toughest Problems As an independent nonprofit engineering innovation company, Draper provides engineering services directly to government, industry, and academia. We work on teams as prime contractors or subcontractors and participate as collaborators in consortia. Our strong commitment to delivering working solutions allows us to apply ourselves to a variety of domains from space to undersea —...
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement...
The AI In-Silico Lab, powered by Bio Foundation Models — enabling virtual experiments for target ID, RNA design, and patient stratification.
3Brain AG is a Swiss deep-tech life science company that develops custom-made semiconductor microchips to create cell-electronic interfaces. Their technology links biological networks to computers, enabling researchers to study electrophysiological activity in brain organoids and cultures. Their mission is to empower life scientists to probe intelligent networks and accelerate biomedical discoveries for the benefit of patients.
Piramal Pharma Limited is a global pharmaceutical company that provides end-to-end drug development and manufacturing services (CDMO), complex hospital generics, and consumer healthcare products.
Prelude Therapeutics Incorporated is a clinical-stage precision oncology company dedicated to discovering and developing innovative, novel precision cancer medicines for underserved patients. The company focuses on targeting key drivers of cancer cell growth and resistance, with a pipeline that includes JAK2V617F and KAT6A programs and degrader antibody conjugates to treat various cancers, including breast cancer and myeloproliferative neoplasms.
Sitero is a next-generation, site-focused clinical research organization (CRO) for life sciences and institutional research organizations that helps get treatments to market safer and faster through tech-forward services that streamline research. Accelerate your clinical trial, drive compliance and safety, and unlock innovation with access to powerful technology and world-class services. Sitero combines the expertise of a tenured team with a...
Vivodyne builds lifelike, lab-grown human tissues and runs AI-driven, robotic, high-throughput preclinical testing to generate multimodal human data (imaging, single-cell transcriptomics, proteomics). Their platform aims to replace animal models by producing predictive human physiological insights at scale, accelerating therapeutic discovery and improving the selection of drug candidates before clinical trials.
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader medicines for serious diseases, including oncology, autoimmune, inflammatory, cardiovascular, and cardiometabolic conditions. Its QuEEN platform combines proprietary molecular glue libraries with proteomics, structural biology, computational chemistry, and AI/machine learning to discover and develop treatments aimed at disease-driving proteins and pathways long considered undruggable across multiple therapeutic...
CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring,...
Paradigm Health is a technology company rebuilding the clinical research ecosystem through AI-powered infrastructure. Its mission is to create equitable access to clinical trials for any patient, anywhere, by enabling healthcare providers to participate in research with significantly fewer resources. The company focuses primarily on oncology clinical trials, while expanding into neuroscience, cardiovascular disease, and metabolic conditions.
FRAUD ALERT: Please take note that it has come to our attention that individuals purporting to work for Repligen are reaching out to prospective job applicants using fraudulent email addresses. All legitimate communications from Repligen will be sent from an individual with an email address ending in @repligen.com. If you have any concerns that a communication may be fraudulent and...
Galatea Bio is an innovative, venture-backed biotechnology company dedicated to advancing precision health for all. The company leverages world-class ancestry algorithms to better understand underserved Latin American populations while maintaining a strong commitment to ethical research. It partners with pharmaceutical and life sciences organizations to design and execute projects that utilize human genetic diversity to solve acute problems in biomedicine.
Gerresheimer is the global partner for pharma, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence, focus on quality and customers....
Bexorg is a techbio company developing a first-of-its-kind integrated platform for central nervous system (CNS) drug discovery and development. By combining its proprietary BrainEx whole-brain perfusion technology with the XO Digital AI engine, Bexorg generates high-fidelity human brain molecular datasets to identify novel targets and biomarkers for neurological disorders, aiming to significantly reduce the high failure rate of CNS clinical...
Epicrispr Biotechnologies is a biotechnology company developing ultracompact therapies to modulate gene expression in vivo using the smallest known Cas protein, CasMINI
Autolus is a CAR T cell therapy company. We are applying our extensive programming capabilities to develop advanced autologous T cell therapies that have the potential to deliver life-changing therapies to patients with cancer and autoimmune diseases.
Our mission is to identify, develop and deliver life-changing therapies to people living with rare disease. #InRareForLife Community Guidelines: https://travere.com/community-guidelines/
IDEX (NYSE: IEX) is a company that has undoubtedly touched your life in some way. In fact, IDEX businesses make thousands of products that are mission-critical components in everyday activities. Chances are the car you’re driving has a BAND-IT® clamp holding your side airbag safely in place. If you were ever in a car accident, a Hurst Jaws of Life®...
IDEX Corporation's Top Stability & Growth Strengths
Strong Market Position & Advantage: Feedback suggests IDEX holds leading positions across specialized, mission-critical niches with well-known brands (e.g., Viking Pump, SANDPIPER/Warren Rupp, Semrock, HURST). Company materials emphasize premium pricing, sticky OEM/aftermarket relationships, and S&P 500 visibility that reinforce defensible advantages.
Strong Revenue Growth: Feedback suggests the company posted record 2025 sales and delivered higher Q1 2026 sales and record orders, with management raising full-year organic growth guidance. Growth is concentrated in Health & Science Technologies with double-digit organic gains and tailwinds from semiconductors, data centers, and space/defense.
Profitability: Feedback suggests high-20s EBITDA margins, strong free cash flow, and price/cost discipline underpin a mature, scalable financial model. Recent results highlight durable margins alongside increased earnings and guidance, consistent with a high-quality industrial franchise.

































